Latest News
OPEC+ considers further action to support oil market in 2021
The Organization of Petroleum Exporting Countries and allies started meetings on Monday to consider new measures to support the oil market in 2021 as the pandemic continues to impact demand and prices.
Tuesday preview: US retail sales, Easyjet in the spotlight
Investors' attention on Tuesday will be mainly on the US, where a deluge of macroeconomic data are due out.
US close: Dow registers record close following Moderna update
Wall Street stocks turned in solid gains on Monday as the Dow Jones registered a record close thanks to further positive vaccine headlines.
US open: Dow on track for record close amid vaccine optimism
Wall Street stocks turned in early gains on Monday as the Dow Jones was on track for a record close thanks to further positive vaccine headlines.
Europe close: Stocks start week on a strong note, banks in focus
European markets started the week on a bullish note after US biotechnology outfit Moderna delivered another dose of good news, announcing a remarkable 94. 5% efficacy for its Covid-19 vaccine.
Aramco seeks to raise cash via multi-tranche bond deal
Saudi Aramco said on Monday it has hired a group of banks to plan its multi-tranche US dollar-denominated bond deal as it seeks to raise cash.
Brussels set to pass review of merger between Liberty Global and Telefonica to CMA
Brussels will cede authority to the Competitions and Markets Authority to decide whether or not to approve the merger of Liberty Global and Telefonica's business units in the UK.
London close: Stocks finish firmer on latest vaccine news
London stocks closed in positive territory on Monday, with sentiment underpinned by vaccine optimism and solid Chinese data.
Tricorn finds 'various matters' after internal review
Tube manipulation specialist Tricorn Group updated the market on its trading on Monday, reporting that following the appointment of Michael Stock as group finance director and the hiring of a new finance team, an internal review of the group’s performance was conducted.
Botswana Diamonds progresses Sekaka acquisition
Botswana Diamonds announced on Monday that all conditions for the acquisition of Sekaka Diamonds had now been satisfied, adding that Sekaka's prospecting licence, which holds the KX36 high-grade kimberlite pipe, had also been extended for a further two years, to 30 September 2022.
Broker tips: Tyman, Informa
Analysts at Canaccord Genuity raised their target price on door and window components supplier Tyman from 285. 0p to 325. 0p on Monday, citing recent macro and sector news-flow.
Liberum stays at 'buy' on Anglo American after Chinese industrial production data
Analysts at Liberum reiterated their 'buy' recommendation and 2,400p target price for shares of Anglo American following the release of "strong" October industrial production data out of China, including for infrastructure.
Director dealings: St Modwen CEO makes share purchase
St Modwen Properties revealed on Monday that chief executive officer Sarwjit Sambhi had acquired 25,200 ordinary shares in the FTSE 250-listed property investment and development business.
Morgan Stanley says keep faith with V-shaped recovery
Morgan Stanley predicted a V-shaped global economic recovery and advised investors to take 'overweight' positions on global equities and credit as the world emerges from a turbulent 2020.
FTSE 100 movers: IAG flies higher on vaccine hopes; Ocado retreats
London’s FTSE 100 was up 1. 6% at 6,420. 23 in afternoon trade on Monday as investors cheered news that a Covid-19 vaccine by Moderna has been shown to be 95% effective.
Home Depot to buy HD Supply in $8bn deal
US home improvement retailer Home Depot has agreed to buy HD Supply Holdings, a distributor of maintenance, repair and operations (MRO) products to the multifamily and hospitality end markets, in a $8bn deal.
FTSE 250 movers: Travel, leisure stocks gain on vaccine news; AO drops
London’s FTSE 250 was up 2% at 19,649. 77 in afternoon trade on Tuesday after US biotech firm Moderna said its Covid-19 vaccine had been shown to be 95% effective.
Canaccord raises target price on Tyman
Analysts at Canaccord Genuity raised their target price on door and window components supplier Tyman from 285. 0p to 325. 0p on Monday, citing recent macro and sector news-flow.
Moderna reports 95% efficacy in Covid vaccine trials, stocks jump
Markets rallied on Monday after US biotech Moderna said its experimental Covid-19 vaccine had proved nearly 95% effective in phase 3 trials.
BofA sees broad access to Moderna Covid-19 vaccine in Q2 2021
Analysts at Bank of America hiked their target price for shares of US biotechnology outfit Moderna after interim clinical data from its Covid-19 vaccine trial met the high bar for efficacy, forecasting that Emergency Use Approval (EUA) might arrive before year-end 2020 and full authorisation by quarter two of 2021.